| Lee Berman, MD | |
|
200 Mercy Dr Ste 201, Dubuque, IA 52001 | |
| (563) 584-3500 | |
| (563) 584-3520 |
| Full Name | Lee Berman |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 13 Years |
| Location | 200 Mercy Dr Ste 201, Dubuque, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508271867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD44863 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Dubuque Medical Center | Dubuque, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Specialty Clinic | 3375639586 | 59 |
| Medical Associates Clinic Pc | 3870491228 | 192 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
People want their toenails to look great in the summer. But many people allow their toenails to grow too long, which can cause discoloration, blisters and other problems, according to Loyola University Medical Center podiatrist Dr. Coleen Napolitano.
According to new guidelines released by the American Heart Association, almost all women are at risk of heart disease and doctors should consider prescribing a daily aspirin for them.
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
› Verified 2 days ago
| Entity Name | Medical Associates Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457300790 PECOS PAC ID: 3870491228 Enrollment ID: O20031223000311 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
People want their toenails to look great in the summer. But many people allow their toenails to grow too long, which can cause discoloration, blisters and other problems, according to Loyola University Medical Center podiatrist Dr. Coleen Napolitano.
According to new guidelines released by the American Heart Association, almost all women are at risk of heart disease and doctors should consider prescribing a daily aspirin for them.
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
› Verified 2 days ago
| Entity Name | Mercy Medical Center-dubuque |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659348506 PECOS PAC ID: 2668467168 Enrollment ID: O20040415000450 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
People want their toenails to look great in the summer. But many people allow their toenails to grow too long, which can cause discoloration, blisters and other problems, according to Loyola University Medical Center podiatrist Dr. Coleen Napolitano.
According to new guidelines released by the American Heart Association, almost all women are at risk of heart disease and doctors should consider prescribing a daily aspirin for them.
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
› Verified 2 days ago
| Entity Name | Crescent Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720146319 PECOS PAC ID: 0345343158 Enrollment ID: O20070806000462 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
People want their toenails to look great in the summer. But many people allow their toenails to grow too long, which can cause discoloration, blisters and other problems, according to Loyola University Medical Center podiatrist Dr. Coleen Napolitano.
According to new guidelines released by the American Heart Association, almost all women are at risk of heart disease and doctors should consider prescribing a daily aspirin for them.
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
› Verified 2 days ago
| Entity Name | Mercy Specialty Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386832764 PECOS PAC ID: 3375639586 Enrollment ID: O20071019000139 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
People want their toenails to look great in the summer. But many people allow their toenails to grow too long, which can cause discoloration, blisters and other problems, according to Loyola University Medical Center podiatrist Dr. Coleen Napolitano.
According to new guidelines released by the American Heart Association, almost all women are at risk of heart disease and doctors should consider prescribing a daily aspirin for them.
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lee Berman, MD 200 Mercy Dr Ste 201, Dubuque, IA 52001-7300 Ph: (563) 584-3500 | Lee Berman, MD 200 Mercy Dr Ste 201, Dubuque, IA 52001 Ph: (563) 584-3500 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
People want their toenails to look great in the summer. But many people allow their toenails to grow too long, which can cause discoloration, blisters and other problems, according to Loyola University Medical Center podiatrist Dr. Coleen Napolitano.
According to new guidelines released by the American Heart Association, almost all women are at risk of heart disease and doctors should consider prescribing a daily aspirin for them.
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
› Verified 2 days ago
Peter Joseph Szeibel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1015 Valentine Dr, Dubuque, IA 52003 Phone: 563-556-8566 | |
Mr. Mark W Walter, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1690 Elm St Ste 300, Dubuque, IA 52001 Phone: 563-690-2850 Fax: 563-582-5335 | |
Dr. Roger D. Shafer, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 300 N Grandview Ave, Dubuque, IA 52001 Phone: 563-589-2529 Fax: 563-589-2686 | |
Adib Kassas, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3500 Fax: 563-584-3520 | |
Anupama Upadhyay, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3500 Fax: 563-584-3520 | |
Dr. Mark Wilbur Fortson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2255 Jfk Rd, Dubuque, IA 52002 Phone: 563-582-4357 Fax: 563-582-5718 | |
Yasyn Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Mercy Dr, Suite 201, Dubuque, IA 52001 Phone: 563-584-3500 Fax: 563-584-3520 |